What is the biosimilar for Neupogen?

Zarxio (filgrastim-sndz) and Nivestym (filsgrastim-aafi) are biosimilars to Neupogen and approved for most indications as Neupogen. The FDA defines biosimilar as a biological product that is highly similar to and has no clinically meaningful differences from an existing FDA-approved reference product (1-5).

What is the generic name for Neupogen?

Neupogen, Granix and Zarxio are trade names for filgrastim. Granulocyte – colony stimulating factor (G-CSF) is another name for filgrastim. In some cases, health care professionals may use the trade name Neupogen, Granix or Zarxio when referring to the generic drug name filgrastim.

Is Neupogen and Zarxio the same?

What is the reference biologic product for Zarxio? The brand name biologic “equivalent” for Zarxio is Neupogen (filgrastim). Neupogen and Zarxio are used to increase white blood cell counts to help reduce the risk of infection, as in patients receiving chemotherapy.

What was the first FDA biosimilar?

Filgrastim-sndz
Filgrastim-sndz is the first biosimilar drug approved by the FDA for use in the United States.

What is another name for Coumadin?

Warfarin, Oral Tablet. Warfarin oral tablet is available as both a generic and brand-name drug. Brand name: Jantoven (Coumadin was discontinued in April 2020). Warfarin comes only as a tablet you take by mouth.

Is Neulasta a biosimilar?

The US Food and Drug Administration (FDA) has approved Udencya as a biosimilar of Neulasta, which means it is “highly similar to, and has no clinically meaningful differences from” Neulasta – it is just as safe and effective and used in the same way. A biosimilar product is like a generic version of a traditional drug.

What is biosimilars in pharmacy?

A biosimilar is a biological product that is highly similar to and has no clinically meaningful differences from an existing FDA-approved reference product.

What are biosimilars used for?

The U.S. Food and Drug Administration has approved biosimilar medications to treat conditions such as cancer, diabetes, Crohn’s disease, colitis, rheumatoid arthritis, psoriasis, and more.

Is there an alternative to Neulasta?

UDENYCA® (pegfilgrastim-cbqv) A Safe, Effective, and Affordable Alternative to Neulasta® (pegfilgrastim)

What are neupogen and Zarxio used for?

Neupogen and Zarxio are used to increase white blood cell counts to help reduce the risk of infection, as in patients receiving chemotherapy. For more information on Neupogen see the manufacturer website here.

What is the newest approved bio-similar drug?

Pegfilgrastim-apgf (Nyvepria) Pegfilgrastim-apgf, the newest approved bio-similar, has been evaluated in two phase I studies that resulted in its recent FDA approval. The first phase I trial was a three-way study that compared pegfilgrastim-apgf to both the US and EU pegfilgrastim reference products.

What does the US biosimilar approval mean for Amneal?

“The U.S. approval of our first biosimilar is a very significant milestone for Amneal. Biosimilars represent the next wave of providing access to affordable medicines in the U.S. Amneal is building a global biosimilars business by leveraging partner assets to start and then leveraging our own key capabilities over time.

Is Pegfilgrastim (Neulasta) a competitive drug?

With medications like pegfilgrastim (Neulasta) serving as the reference product, other manufacturers now have a pathway to getting competing products to market. With more of these new products rapidly gaining approval and pharmacy benefit manager preferences changing just as quickly, providers are struggling to keep up.